PE20250746A1 - Composicion acuosa - Google Patents
Composicion acuosaInfo
- Publication number
- PE20250746A1 PE20250746A1 PE2024002054A PE2024002054A PE20250746A1 PE 20250746 A1 PE20250746 A1 PE 20250746A1 PE 2024002054 A PE2024002054 A PE 2024002054A PE 2024002054 A PE2024002054 A PE 2024002054A PE 20250746 A1 PE20250746 A1 PE 20250746A1
- Authority
- PE
- Peru
- Prior art keywords
- aqueous composition
- compositions
- aqueous
- wholly
- polyolefin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022050275 | 2022-03-25 | ||
| PCT/JP2023/011739 WO2023182480A1 (ja) | 2022-03-25 | 2023-03-24 | 水性組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20250746A1 true PE20250746A1 (es) | 2025-03-13 |
Family
ID=88101709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2024002054A PE20250746A1 (es) | 2022-03-25 | 2023-03-24 | Composicion acuosa |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20250213510A1 (https=) |
| EP (1) | EP4483867A1 (https=) |
| JP (1) | JPWO2023182480A1 (https=) |
| KR (1) | KR20240159636A (https=) |
| CN (1) | CN118973561A (https=) |
| AU (1) | AU2023240729A1 (https=) |
| CA (1) | CA3254664A1 (https=) |
| CL (1) | CL2024002831A1 (https=) |
| IL (1) | IL315871A (https=) |
| MA (1) | MA67594B1 (https=) |
| MX (1) | MX2024011634A (https=) |
| PE (1) | PE20250746A1 (https=) |
| TW (1) | TW202400133A (https=) |
| WO (1) | WO2023182480A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4806956B2 (ja) * | 2004-04-20 | 2011-11-02 | 大正製薬株式会社 | 点眼用液剤 |
| US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| JP2009078977A (ja) * | 2007-09-25 | 2009-04-16 | Japan Health Science Foundation | 心筋の小胞体ストレス抑制剤 |
| EP2127638A1 (en) * | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
| US8962686B2 (en) * | 2010-04-28 | 2015-02-24 | The Chinese University Of Hong Kong | Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| WO2018164113A1 (ja) * | 2017-03-06 | 2018-09-13 | 学校法人 慶應義塾 | マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤 |
| WO2018181294A1 (ja) * | 2017-03-27 | 2018-10-04 | 興和株式会社 | 医薬製剤 |
| JP7474706B2 (ja) | 2018-12-18 | 2024-04-25 | 参天製薬株式会社 | ４－フェニル酪酸を含有する老視の治療または予防剤 |
-
2023
- 2023-03-24 WO PCT/JP2023/011739 patent/WO2023182480A1/ja not_active Ceased
- 2023-03-24 JP JP2024509249A patent/JPWO2023182480A1/ja active Pending
- 2023-03-24 CN CN202380029644.0A patent/CN118973561A/zh active Pending
- 2023-03-24 TW TW112111197A patent/TW202400133A/zh unknown
- 2023-03-24 KR KR1020247035255A patent/KR20240159636A/ko active Pending
- 2023-03-24 CA CA3254664A patent/CA3254664A1/en active Pending
- 2023-03-24 PE PE2024002054A patent/PE20250746A1/es unknown
- 2023-03-24 US US18/847,501 patent/US20250213510A1/en active Pending
- 2023-03-24 IL IL315871A patent/IL315871A/en unknown
- 2023-03-24 MA MA67594A patent/MA67594B1/fr unknown
- 2023-03-24 EP EP23775073.2A patent/EP4483867A1/en active Pending
- 2023-03-24 MX MX2024011634A patent/MX2024011634A/es unknown
- 2023-03-24 AU AU2023240729A patent/AU2023240729A1/en active Pending
-
2024
- 2024-09-23 CL CL2024002831A patent/CL2024002831A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202400133A (zh) | 2024-01-01 |
| US20250213510A1 (en) | 2025-07-03 |
| CN118973561A (zh) | 2024-11-15 |
| IL315871A (en) | 2024-11-01 |
| CA3254664A1 (en) | 2025-07-03 |
| MA67594A1 (fr) | 2025-07-31 |
| CL2024002831A1 (es) | 2025-01-24 |
| JPWO2023182480A1 (https=) | 2023-09-28 |
| MA67594B1 (fr) | 2026-01-30 |
| WO2023182480A1 (ja) | 2023-09-28 |
| EP4483867A1 (en) | 2025-01-01 |
| AU2023240729A1 (en) | 2024-10-03 |
| KR20240159636A (ko) | 2024-11-05 |
| MX2024011634A (es) | 2024-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20200998T1 (hr) | Postupak i sastav za liječenje okularne hipertenzije i glaukoma | |
| ECSP088159A (es) | Formulaciones de inmunoconjugado | |
| PY2117017A (es) | Ácido sulfúrico modificado y usos del mismo | |
| ATE376423T1 (de) | Gelierende wässrige pharmazeutische zusammensetzungen | |
| HN1999000088A (es) | Composiciones estabilizadas | |
| PA8544401A1 (es) | Metodo para fabricar una composicion farmaceutica de dosis baja que tiene una distribucion y potencia del farmaco uniformes | |
| GT200200105A (es) | Nueva composicion farmaceutica | |
| CO5580737A2 (es) | Composiciones y metodos para administrar unguentos antibacterianos, antimicoticos y antivirales a las cavidades bucal, nasal o vaginal | |
| CL2020002252A1 (es) | Formulación oftálmica. | |
| NO20025355D0 (no) | Farmasöytisk preparat som omfatter en faktor VIIa og en faktor XIII | |
| UY38345A (es) | Composición farmacéutica que comprende agente antiplaquetario e inhibidor de la secreción de ácido g | |
| JP2017514924A5 (https=) | ||
| ATE404176T1 (de) | Stabilisierte lyophilisierte zubereitungen mit gewebefaktor-inhibitor (tfpi) oder varianten des gewebefaktor-inhibitors | |
| AR118571A1 (es) | Composición farmacéutica acuosa de anticuerpo anti-il17a | |
| BR122021012549B8 (pt) | Composição de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva | |
| AR055838A1 (es) | Formulaciones para microproyecciones recubiertas que tienen solubilidad controlada | |
| PE20250746A1 (es) | Composicion acuosa | |
| NO20023875L (no) | Stabilt nasalt, oralt eller sublingualt anvendbart preparat | |
| PE20250835A1 (es) | Composiciones y uso de la tirzepatida | |
| BRPI0511923A (pt) | composições estabilizadas que compreendem um agente terapeuticamente ativo ácido cìtrico ou uma base conjugada e dioxido de cloro | |
| MX2022007162A (es) | Forma de dosificacion que comprende un agente alcalino y una capa de revestimiento enterico. | |
| MX2023013617A (es) | Composicion monomerica, composicion de resina metacrilica y cuerpo moldeado de resina. | |
| CR7730A (es) | Composiciones antimicrobianas sinergeticas, con bajo contenido de formaldehido libre, estables de donadores de aldehido y acido dehidroacetico | |
| EP1641486A4 (en) | Stable, aqueous solution of human erythropoietin, not containing serum albumin | |
| NZ591529A (en) | Chemical composition for skin care formulations |